Overview

Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test how rifampin affects the removal of BMS-247550 (ixabepilone) from the body.
Phase:
Phase 1
Details
Lead Sponsor:
R-Pharm
Treatments:
Epothilones
Rifampin